PR94774

KOCHI, India, March 2, 2022 /PRNewswire=KYODO JBN/ --

    - Patients can use the wearable, non-invasive device to measure six body

parameters including blood glucose, blood pressure, heart rate, blood oxygen,

respiratory rate and 6-lead ECG, from the comfort of their home

    - The device, connected to the smart phone, can serve as a micro-bedside

monitor in rural clinics

Amrita University has developed a device for home-monitoring of glucose and

blood pressure. Amrita Spandanam, as the device is called, will be sold online

and through pharmacists across the country.

Photo -

https://mma.prnewswire.com/media/1756993/Amritapuri_Campus_Admin_Building_Drone.jpg

Developed and patented by the varsity's Centre for Wireless Networks and

Applications, it is a wearable, six-in-one device that is an excellent

replacement for a bedside monitor. It can be used to measure six body

parameters including blood glucose, blood pressure, heart rate, blood oxygen,

respiratory rate, and 6-lead ECG.

Said Dr Maneesha V Ramesh, the Provost of Amrita University who led the team of

researchers: "Amrita Spandanam is a revolutionary device that has bagged

several US patents, with results published in top scientific journals. It

offers a quick, easy, affordable and non-invasive way to monitor and detect

diabetes, cardiovascular diseases, hypertension, sleep apnea and allergy

attacks from the comfort of one's home. The product was extensively tested on

1000 patients at Amrita Hospital in Kochi and various remote clinics in Kerala.

Last year, these devices were successfully deployed at Amrita Hospital to

remotely monitor the progression of severity in COVID-19 patients."

Amrita Spandanam is connected to the patient's smartphone. The data is sent to

a secure hospital cloud which enables any doctor authorized by the patient to

access the vital parameters remotely from any location. The product also

integrates multiple -learning models that can predict the potential

deterioration of patients' health and provide early warning decision support to

doctors for acute hypotensive episodes, sepsis, sleep apnea, and atrial

fibrillation.

About Amrita University

http://www.amrita.edu

Amrita partners with academic, industry and governmental institutions across

the world to accomplish human-centered, translational, and groundbreaking

research. Some of Amrita's partners include Harvard University, Columbia

University, King's College London, KTH - Royal Institute of Technology, VU

Amsterdam, the British Geological Society, University of Oxford, Italian

National Research Council, Deakin University, and the University of Tokyo. Sri

Mata Amritanandamayi Devi (Amma), a world-renowned humanitarian leader is the

founder, Chancellor, and guiding light of Amrita University.

Contact: Dr. Maneesha Ramesh, maneesha@amrita.edu

SOURCE  Amrita University